Absci director granted RSUs and stock options
Absci Corp director Mary T. Szela received new equity awards as part of her compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
Absci Corp director Mary T. Szela received new equity awards as part of her compensation. She was granted 8,400 Restricted Stock Units, each representing one share of common stock, and 33,200 stock options with a per-share exercise price of $7.34.
The RSUs and options will vest in full on the earlier of the first anniversary of the grant date or Absci’s next annual stockholder meeting, provided she continues serving the company through that date. After these grants, she directly holds 8,400 RSUs and 33,200 options scheduled to expire on June 3, 2036.
Insider Trade Summary
Grant/Award: 41,600 shares
Grant/Award
2 txns
Insider
Szela Mary T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 33,200 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 8,400 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 33,200 contracts (Direct);
Common Stock — 8,400 shares (Direct)
Footnotes (2)
- F1. The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.
- F2. The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.
Key Figures
RSU grant: 8,400 shares
Stock options granted: 33,200 options
Option exercise price: $7.34 per share
+3 more
6 metrics
RSU grant
8,400 shares
Restricted Stock Units granted to director on June 4, 2026
Stock options granted
33,200 options
Stock Option (right to buy) granted on June 4, 2026
Option exercise price
$7.34 per share
Conversion/exercise price for 33,200 options
RSU holding after grant
8,400 shares
Total common stock underlying RSUs following transaction
Option holding after grant
33,200 options
Total options held following transaction
Option expiration date
June 3, 2036
Expiration date for the 33,200 stock options
Key Terms
Restricted Stock Units ("RSUs"), Absci Corporation 2021 Stock Option and Incentive Plan, Stock Option (right to buy), vest and be settled in full, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Absci Corporation 2021 Stock Option and Incentive Plan financial
"Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan."
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)" with underlying security title Common Stock."
vest and be settled in full financial
"The RSUs shall vest and be settled in full on the earlier of the first anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."
continuous service financial
"subject to the Reporting Person's continuous service to the Issuer through such date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Absci (ABSI) grant to director Mary T. Szela?
Absci granted Mary T. Szela 8,400 Restricted Stock Units and 33,200 stock options. Each RSU equals one share of common stock, while the options allow her to buy shares at a fixed exercise price.
What is the exercise price of Mary T. Szela’s Absci (ABSI) stock options?
The granted stock options have an exercise price of $7.34 per share. This means Szela can buy Absci common stock at $7.34 once the options vest, regardless of the market price at that time.
When do Mary T. Szela’s new Absci (ABSI) RSUs and options vest?
Both the RSUs and stock options vest in full on the earlier of the first anniversary of the grant date or Absci’s next annual stockholder meeting. Vesting is conditioned on Szela’s continuous service through that date.
How many Absci (ABSI) stock options does Mary T. Szela hold after this filing?
Following this grant, Szela holds 33,200 stock options directly. These options relate to Absci common stock and are scheduled to expire on June 3, 2036 if not exercised by then.
Are Mary T. Szela’s Absci (ABSI) awards open-market purchases of stock?
No. The filing shows compensation-related grants: 8,400 RSUs and 33,200 stock options. These are awards from Absci, not open-market purchases, and they vest based on her continued board service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates